| (84) |
Designated Contracting States: |
|
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL
NO PL PT RO RS SE SI SK SM TR |
| (30) |
Priority: |
05.10.2015 US 201562237394 P
19.02.2016 US 201662297426 P
|
| (43) |
Date of publication of application: |
|
30.12.2020 Bulletin 2020/53 |
| (60) |
Divisional application: |
|
22163286.2 |
| (62) |
Application number of the earlier application in accordance with Art. 76 EPC: |
|
16782371.5 / 3359184 |
| (73) |
Proprietor: Precision Biosciences, Inc. |
|
Durham, NC 27701 (US) |
|
| (72) |
Inventors: |
|
- JANTZ, Derek
Durham, NC 27701 (US)
- SMITH, James, Jefferson
Morrisville, NC 27560 (US)
- NICHOLSON, Michael, G.
Chapel Hill, NC 27517 (US)
- MACLEOD, Daniel, T.
La Jolla, CA 92037 (US)
- ANTONY, Jeyaraj
Chapel Hill, NC 27516 (US)
- BARTSEVICH, Victor
Durham, NC 27713 (US)
|
| (74) |
Representative: Grund, Martin et al |
|
Grund Intellectual Property Group
Patentanwalt und Solicitor PartG mbB
Postfach 44 05 16
80754 München
80754 München (DE) |
| (56) |
References cited: :
WO-A1-2013/176915
WO-A1-2014/191527
WO-A1-2017/062439
WO-A2-2017/180989
|
WO-A1-2014/191128
WO-A1-2015/057980
WO-A1-2017/156484
|
|
| |
|
|
- L. POIROT ET AL: "Multiplex Genome-Edited T-cell Manufacturing Platform for "Off-the-Shelf"
Adoptive T-cell Immunotherapies", CANCER RESEARCH, vol. 75, no. 18, 16 July 2015 (2015-07-16)
, pages 3853-3864, XP055221500, ISSN: 0008-5472, DOI: 10.1158/0008-5472.CAN-14-3321
- MACLEOD DANIEL T ET AL: "Generation of a Novel Allogeneic CAR T Cell Platform Utilizing
an Engineered Meganuclease and AAV Donor Template to Achieve Efficient Disruption
of T Cell Receptor Expression and Simultaneous Homology-Directed Insertion of a CD19
CAR", MOLECULAR THERAPY, NATURE PUBLISHING GROUP, GB, vol. 24, no. Suppl.1, 1 May
2016 (2016-05-01), page S156, XP009192715, ISSN: 1525-0016
- BAECKSEUNG LEE ET AL: "323. Efficient Generation of CART Cells by Homology Directed
Transgene Integration into the TCR-Alpha Locus", MOLECULAR THERAPY, vol. 24, no. s1,
1 May 2016 (2016-05-01), pages S130-s130, XP055338267, GB ISSN: 1525-0016, DOI: 10.1016/S1525-0016(16)33132-X
- MARC CARTELLIERI ET AL: "Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy
of Cancer", JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, vol. 21, no. 4, 1 January 2010
(2010-01-01), pages 427-13, XP055206629, ISSN: 1110-7243, DOI: 10.1155/2010/956304
|
|
